In addition to dodging its fair share of taxes, Pfizer—maker of Celebrex, Lipitor, Lyrica, and Viagra, among many other health-care products—has also been aggressively raising … Pfizer: tax dodger, price gougerRead more
Medicine
Posted inUncategorized
It’s Time to Trust China’s and Russia’s Vaccines
While the richest countries in the world are grappling with shortages of Covid-19 vaccines, some of the poorest worry about getting vaccines at all. Yet … It’s Time to Trust China’s and Russia’s VaccinesRead more
Posted inUncategorized
Don’t Let Drug Companies Create a System of Vaccine Apartheid
It has been over one year since the World Health Organization issued a Public Health Emergency of International Concern declaration for COVID-19. Yet despite pledges … Don’t Let Drug Companies Create a System of Vaccine ApartheidRead more
Posted inUncategorized
U.S. & Other Wealthy Nations Block Effort to Waive Vaccine Patent Rights
The United States and other wealthy members of the World Trade Organization have blocked a push by dozens of developing countries to waive patent rights … U.S. & Other Wealthy Nations Block Effort to Waive Vaccine Patent RightsRead more
Posted inUncategorized
EpiPen Maker Mylan Has 2nd Highest Executive Pay in Industry
a new analysis by The Wall Street Journal shows the pharmaceutical giant Mylan, which has come under fire for hiking the cost of the life-saving … EpiPen Maker Mylan Has 2nd Highest Executive Pay in IndustryRead more
Posted inCapitalism / Medicine / Patent / ToMl
End Big Pharma Monopoly on COVID Vaccine Supply & Price
As rich countries race to roll out their vaccination programs, leaders in the Global South and global health advocates are increasingly decrying vaccine hoarding that … End Big Pharma Monopoly on COVID Vaccine Supply & PriceRead more
Posted inMedicine / ToMl
Big Pharma Prepares to Profit From the Coronavirus
As the new coronavirus spreads illness, death, and catastrophe around the world, virtually no economic sector has been spared from harm. Yet amid the mayhem … Big Pharma Prepares to Profit From the CoronavirusRead more